Bionano announces amendment to senior secured convertible debentures in debt restructuring that improves cash runway

San diego, dec. 31, 2024 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced that it has entered into a settlement agreement and amendment to its outstanding senior secured convertible debentures due may 26, 2024 (the “amendment”). importantly the amendment defers the company's december 2024 amortization payment and reduces the payments due in january 2025 through july 2025 from $1,000,000 per month to $500,000 per month.
BNGO Ratings Summary
BNGO Quant Ranking